A Cardiac Liability Study of Varegacestat in Healthy Participants

NCT06855264 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: varegacestat
DRUG: Placebo
DRUG: Moxifloxacin 400 mg

Sponsor

Immunome, Inc.